This trial is active, not recruiting.

Condition uveitis
Sponsor Moorfields Eye Hospital NHS Foundation Trust
Start date September 2011
End date December 2018
Trial size 1500 participants
Trial identifier NCT01983488, LIGS10201


This study is aimed at investigating the long term clinical outcome of patients with uveitis.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Patient with a clinical diagnosis of Uveitis.

Primary Outcomes

Best Corrected Visual Acuity
time frame: up to 10 years

Secondary Outcomes

Causes of visual loss
time frame: First follow-up, years 1,2,5,10, Final follow-up

Eligibility Criteria

All participants of any age.

Inclusion Criteria: - Clinical Diagnosis of Uveitis. Exclusion Criteria: - No follow-up data.

Additional Information

Official title Clinical Outcome and Causes of Visual Loss in Uveitis
Principal investigator Sue Lightman, PhD,FRCOphth
Description Patients will be included if they are treated for uveitis and have had repeat follow-up. Data will be gathered from the entire length of the patients follow-up. The main outcome measures will be: Change from baseline of Best corrected visual acuity (BCVA)at 10 years Causes of vision loss (≤6/15, VL) and severe vision loss (≤6/60, SVL) at 10 years Number of clinical visits at 10 years.
Trial information was received from ClinicalTrials.gov and was last updated in March 2017.
Information provided to ClinicalTrials.gov by Moorfields Eye Hospital NHS Foundation Trust.